Discordant HER2/Neu Status of Breast Cancer.

Completed

• Conditions: Malignant Neoplasm of Breast.

• Registration Number: NCT01935739
• Lead Sponsor: National Cancer Institute, Thailand

Brief Summary

The purpose of this study is to determine discordant HER2/neu status of primary breast tumor and metastatic breast cancer cells at regional lymph nodes in node positive breast cancer patients.

Detailed Description

HER2/neu status of primary breast tumor and axillary lymph nodes were tested by IHC staining. In the cases of equivocal result of IHC, FISH test were performed.

The result of HER2/neu status between primary breast tumor and axillary lymph node were analyzed.

Study Timeline

• Study Start: 2010-06
• Primary Completion: 2011-06
• Study Completion: 2011-06
• Study First Submitted: 2013-08-20
• Study First Submitted QC: 2013-08-31
• Status Verified: 2013-09
• Study First Posted: 2013-09-05
• Last Update Submitted: 2013-09-14
• Last Update Posted: 2013-09-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 105

Inclusion Criteria

• Breast cancer patients stage I,II and III with axillary lymph nodes metastasis.

Exclusion Criteria

• Breast cancer patients stage I,II and III without axillary lymph nodes metastasis.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Association of HER2/neu status between primary breast tumor and axillary lymph nodes	up to 1 year	Association of HER2/neu status between primary breast tumor and axillary lymph nodes was analyzed by using the χ2 test

Trial Locations

Locations (1)

National Cancer Institute , Thailand.; 🇹🇭 Ratchathewi, Bangkok, Thailand